Go to PSANZ Homepage
Home
Search
  • About
    • Our People
    • Goals & Strategies
    • Contact Us
  • IMPACT Research
    • IMPACT Network Trials
    • IMPACT Network Trial Endorsement
  • Resources for Researchers
    • Trial Setup
      • Working With Parents
      • Developing A Research Question
      • Good Clinical Practice
      • Trial Registration
      • Trial Committees
      • Funding
      • Ethics & Governance
    • Running A Trial
      • How To Randomise
      • Randomisation Services
      • Data Monitoring Committees
      • Statistical Approaches To Data Monitoring
    • Trial Completion
      • Follow-up
      • Data
      • IPD
      • Cochrane Reviews
  • Clinical Trials
    • Clinical Trials Database
  • Meetings and Events
    • IMPACT Meetings
    • IMPACT Past Meetings
    • Collaborators Meetings
  • Collaborators
    • IMPACT Collaborators
  • Support
    • Useful Links
    • Trial Resources
    • Contact Us
  • Find us on Facebook
  • Follow us on Twitter
Go to PSANZ Homepage

LIFT Trial Information

LIFT Trial Information

Lactoferrin Infant Feeding Trial

Go to the LIFT website

Objective

  • To test the hypothesis that adding bovine lactoferrin (bLF) to feeds in preterm babies of less than 1500 g birth weight will (i) improve survival free from major hospital morbidity (primary composite endpoint); and, (ii) have a beneficial effect on each component of the composite primary endpoint, as well as the number of blood transfusions given, length of hospital stay, time to full enteral feeds and growth to 36 weeks gestation.
  • To conduct a Cost Effectiveness Analysis of bLF in improving survival free from major hospital morbidity (in Australia only).
  • To evaluate the effect of bLF on survival and developmental outcomes at 24 and 36 months corrected gestational age.

Study Design

Multicentre 2-arm, randomised controlled trial.

Study population

Babies with birth weight less than 1500g and less than 7days old.

Intervention

The two arms of the trial comprise:
a. Treatment group: bLF added to breast milk or formula milk once daily
b. Control group: no bLF added to breast milk or formula milk
Study intervention is administered until 34 weeks corrected gestation or for 2 weeks, whichever is longer, or until discharge home, if earlier.

Outcome Measures

Primary outcome: Survival free from (i) 4 morbidities diagnosed or treated in hospital by 36 weeks corrected gestational age: brain injury or chronic lung disease or late onset sepsis or necrotising
enterocolitis (NEC) and from (ii) retinopathy treated according to local guidelines up to discharge from hospital.
Secondary outcomes: Survival; survival without sepsis; brain injury; chronic lung disease; retinopathy treated according to local guidelines up to discharge, late onset sepsis diagnosed 48 hours after birth, NEC diagnosed or treated in hospital by 36 weeks corrected gestational age, time to full enteral feeds, number of blood transfusions, length of hospital stay, growth to 36 weeks gestation, survival and development outcomes at 24 and 36 months corrected gestational age.

Data/power analysis

1,100 infants yields >80% power to show an improvement in relative risk (RRR) of the primary outcome, from 68% in controls to 76 % in infants having bLF, at 2p = 0.05.
Consistency of the treatment effect on the primary endpoint will be evaluated across the following subgroups:
a. birth-weight <1000 g and 1000-1499 g;
b. randomised ≤72 hr and >72 hr from birth;
c. those who received or did not receive probiotics;
d. ≤ 28 weeks and >28 weeks gestation

Commencement date

June, 2014

Investigators and primary contacts

Principal Investigator: Professor William Tarnow Mordi, University of Sydney

Project Manager: Dr Alpana Ghadge

Project Statistician: Dr Andrew Martin

Coordinating Centre: NHMRC Clinical Trials Centre, Locked Bag 77, Camperdown NSW 1450

Telephone: 61-2-9562-5000

Fax: 61-2-9565-1863

Email: lift@ctc.usyd.edu.au

Australia New Zealand Clinical Trials Registry (ANZCTR) Trial Registry Number:

ACTRN12611000247976

  • Find us on Facebook
  • Follow us on Twitter
Visit the PSANZ Main Website
PSANZ

Suite J, Building 3, 19 Bruce Street, Mornington, Victoria, Australia 3931
Tel: 1300 867 224 (Australia) 
Tel: +61 3835 24221 (overseas)
admin@psanz.com.au

  • Privacy Policy
  • Terms of Use
  • © PSANZ
Website designed at The Fount